INOMIXO is an innovative company dedicated to providing multi-omics solutions in the field of life sciences. By integrating AI big data with advanced mass spectrometry platforms, along with our team’s experienced R&D expertise, INOMIXO has developed two primary business segments: academic omics services and biopharmaceutical CRO services.
We offer proteomics, peptidomics, metabolomics, spatial omics, and bioinformatics analysis to academic organizations. Additionally, we provide customized CRO and CMC certification services for the biopharmaceutical industry. We commit to creating a business landscape that delivers robust, professional, and cutting-edge omics solutions for advancing life sciences.
Company Details
- Employees
- 46
- Founded
- 2024
- Address
- Hk, Hk,hong Kong
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- aptbiotech.com
- Keywords
- 蛋白质组学, 代谢组学, 生物医药, 临床检测, 生命科学, Proteomic, Metabolomic.
- HQ
- HK
Inomixo Questions
Inomixo's website is aptbiotech.com
Inomixo's LinkedIn profile is https://hk.linkedin.com/company/inomixo
Inomixo has
46 employees.
View email and phone details for 46
employees at Inomixo.
Inomixo's industry is
Biotechnology Research
Inomixo's top competitors are
Sevo Bioscience,
Rdm Test Equipment Ltd,
Genequantum Healthcare (Suzhou) Co., Ltd,
Theseus Lab, S.r.o.,
Hrain Biotechnology,
Theseus Ai,
Thermocarrier Usa,
Tj Biopharma,
Theseus,
Thermo Carrier.
Inomixo's categories are Biotechnology Research
Inomixo's founding year is 2024
